Stock Events

Sarepta Therapeutics (AB3A.F) Q2 2024 Earnings

AB3A.F -0.75%
1MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-1.62
-0.83
-0.03
0.76

Details

Expected EPS
0.01204824544
Actual EPS
0.3451952
Surprise EPS
0.33
Surprise Percent
+2,765.11%

Description

Sarepta Therapeutics (AB3A.F) has reported earnings of 0.3451952 per share for Q2 2024.

0 Comments

Share your thoughts